Drug Shortage Report for MYLAN-VERAPAMIL SR
Report ID | 137769 |
Drug Identification Number | 02210347 |
Brand name | MYLAN-VERAPAMIL SR |
Common or Proper name | VERAPAMIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
Strength(s) | 120MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | C08DA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-04-12 |
Estimated end date | 2021-06-01 |
Actual end date | 2021-05-25 |
Shortage status | Resolved |
Updated date | 2021-05-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-05-27 | French | Compare |
v7 | 2021-05-27 | English | Compare |
v6 | 2021-05-19 | French | Compare |
v5 | 2021-05-19 | English | Compare |
v4 | 2021-05-11 | French | Compare |
v3 | 2021-05-11 | English | Compare |
v2 | 2021-04-20 | French | Compare |
v1 | 2021-04-20 | English | Compare |
Showing 1 to 8 of 8